Trevor Martin

Chief Executive Officer and Co-Founder, Mammoth Biosciences

Dr. Trevor Martin is a scientist turned entrepreneur who founded Mammoth Biosciences to enable the next generation of CRISPR-based synthetic biology products to read and write the code of life. Mammoth's technology is democratizing diagnostics with a novel class of affordable, effective, and rapid CRISPR-enabled molecular tests that bring the power and accuracy of lab-based testing for any disease into an easy to use disposable paper format usable in the field and at home. The Mammoth platform for developing novel CRISPR systems has also created nano-sized CRISPR proteins that enable the future of in-vivo editing for therapies from rare diseases to cancer. His work has been featured in outlets including FiveThirtyEight and The Atlantic and in addition to many awards including an NSF Graduate Research Fellowship, he is featured in Forbes' 30 Under 30, Fortune's 40 Under 40 and is a Malaria No More "10 to END" innovator.

Subscribe for updates

A weekly update of what’s on the Global Agenda

© 2021 World Economic Forum

Privacy Policy & Terms of Service